Replies to post #53315 on Biotech Values

[walldiver]

Until something unexpectedly amazing happens, one should just assume that INGN and scam should always accompany each other in a sentence.

[microcapfun]

>>Does anybone know why BSRDavid diss'd INGN's last PR?
<<


>> few weeks agoe INGN released a PR that seamed positive.<<

Didn't read what BSRDavid wrote, but I don't see why Introgen's (n+1)st retrospective, Phase 2, data mining PR should be called "positive".

Introgen finished its Advexin head and neck cancer trials ~6 years ago. Doesn't it seem suspicious to you that they are still putting out PRs on the results??? They also started their *unblinded* Phase 3 trials more than 6 years ago but never came close to finishing them - in fact all indications are that they intentionally slowed them down to a near stop a few years ago. Doesn't that make you suspicious? Those Phase 3 trials had clear endpoints that the company had discussed with the FDA. Doesn't it make you suspicious that the company has been trying like crazy to change the rules and move the goalposts for the past 2+ years - especially given that the trials are unblinded and so the company probably knows the results despite claiming otherwise??

I would guess that BSRDavid would answer "yes" to all the above ...

micro